WINTON GROUP Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 201 filers reported holding HERON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$288,000
-72.1%
13,621
-80.4%
0.02%
-38.2%
Q3 2020$1,032,000
-42.1%
69,611
-42.6%
0.03%
-26.1%
Q2 2020$1,783,000
+96.1%
121,190
+56.5%
0.05%
+91.7%
Q1 2020$909,000
-30.8%
77,444
+38.6%
0.02%
+33.3%
Q4 2019$1,313,000
+144.1%
55,867
+92.0%
0.02%
+200.0%
Q3 2019$538,000
+152.6%
29,098
+233.5%
0.01%
+50.0%
Q1 2019$213,0008,7240.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders